Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26FB4PL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,238
Award facts
- Contract value 100% obligated
- $10,238.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,238.10 to AmerisourceBergen Drug Corp for 90-count bottles of Gemtesa 75 mg tablets on November 17, 2025, with completion scheduled for November 18, 2025. This non-competitive, firm fixed-price delivery order will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of federal contract awards primarily through the Defense Logistics Agency. Gemtesa (mirabegron) is a beta-3 agonist used to treat overactive bladder, representing the type of specialized pharmaceutical commodity the contractor regularly supplies to military and veteran healthcare systems. The delivery order was awarded without a set-aside designation under open competition, demonstrating the contractor's established capability to meet federal procurement requirements and execute orders efficiently within the DLA supply chain.
Quick answers
Who was awarded contract SPE2DR26FB4PL?
SPE2DR26FB4PL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 17, 2025.
How much is contract SPE2DR26FB4PL worth?
The government has obligated $10,238 on SPE2DR26FB4PL.
Is contract SPE2DR26FB4PL an order under another contract?
Yes. SPE2DR26FB4PL is a delivery order under SPE2DR25D2208, an indefinite delivery contract.
Was contract SPE2DR26FB4PL competed?
The extent of competition for SPE2DR26FB4PL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award